SCHEMBL19081713

SCHEMBL19081713

c1ccc2c(c1)ccc1oc3c(ccc4oc5cc(-c6c7ccccc7c(-c7cccc8sc9ccccc9c78)c7ccccc67)ccc5c43)c12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRDT Q58F21 1/20 0.34
PRKDC P78527 1/20 0.32
AHR P35869 3/20 0.31
TDP1 Q9NUW8 3/20 0.31
PAX8 Q06710 2/20 0.31
NPC1 O15118 2/20 0.31
RAB9A P51151 1/20 0.31
MEN1 O00255 1/20 0.31
TP53 P04637 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
MAPT P10636 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
KMT2A Q03164 1/20 0.31
ABCG2 Q9UNQ0 3/20 0.31
NQO1 P15559 1/20 0.31
NQO2 P16083 1/20 0.31
CYP1A1 P04798 1/20 0.31
CYP1A2 P05177 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081719 0.93 BRDT (0.34) BRDTPRKDCAHRTDP1PAX8
SCHEMBL17945658 0.89 ALOX5 (0.39) BRDTPRKDCAHRNPC1RAB9A
SCHEMBL17932187 0.89 ALOX5 (0.39) BRDTPRKDCAHRNPC1RAB9A
SCHEMBL19109913 0.87 ALOX5 (0.37) BRDTPRKDCAHRESR2
SCHEMBL23428244 0.85 ABCG2 (0.33) BRDTAHRTDP1PAX8NPC1
SCHEMBL24518991 0.85 BRDT (0.36) BRDTPRKDCTDP1RAB9AMEN1
SCHEMBL24518948 0.85 BRDT (0.36) BRDTPRKDCAHRTDP1NPC1
SCHEMBL23426807 0.85 BRDT (0.37) BRDTPRKDCAHRTDP1RAB9A
SCHEMBL17944288 0.85 BRDT (0.39) BRDTAHRTDP1PAX8MEN1
SCHEMBL19081550 0.84 AHR (0.36) AHRTDP1PAX8NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 BRDT 2777/4885PRKDC 4719/4885AHR 2453/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 BRDT 2777/4885PRKDC 4719/4885AHR 2453/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.